The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Protein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder
Open accessAbstract
Bipolar disorder is one of the most severely debilitating of all medical illnesses. For a large number of patients, outcomes are quite poor. The illness results in tremendous suffering for patients and their families and commonly impairs functioning and workplace productivity. Risks of increased morbidity and mortality, unfortunately, are frequent occurrences as well. Until recently, little has been known about the specific molecular and cellular underpinnings of bipolar disorder. Such knowledge is crucial for the prospect of developing specific targeted therapies that are more effective and that have a more rapid onset of action than currently available treatments. Exciting recent data suggest that regulation of certain signalling pathways may be involved in the aetiology of bipolar disorder and that these pathways may be profitably targeted to treat the disorder. In particular, mania is associated with overactive protein kinase C (PKC) intracellular signalling, and recent genome-wide association studies of bipolar disorder have implicated an enzyme that reduces the activation of PKC. Importantly, the current mainstays in the treatment of mania, lithium (a monovalent cation) and valproate (a small fatty acid) indirectly inhibit PKC. In addition, recent clinical studies with the relatively selective PKC inhibitor tamoxifen add support to the relevance of the PKC target in bipolar disorder. Overall, a growing body of work both on a preclinical and clinical level indicates that PKC signalling may play an important role in the pathophysiology and treatment of bipolar disorder. The development of CNS-penetrant PKC inhibitors may have considerable benefit for this devastating illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PKC inhibitor tamoxifen enhances the capacity of lithium to reduce symptoms of mania in BD [105–107].”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [105]
In the citing paper
“Treatment of BD patients with lithium or valproate inhibits PKC upregulation, normalizing its level to that of euthymic subjects, and increases BDNF levels [105].”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
The extended protein kinase C superfamily
MELLOR, H., & Parker, P. J. (1998) · Biochemical Journal · doi:10.1042/bj3320281 · Cited by 1,539
Baum, A. E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B., Schulze, T. G., Cichon, S., Rietschel, M., Nöthen, M. M., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002012 · Cited by 700
Takai, Y., Kishimoto, A., Inoue, M., & Nishizuka, Y. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41009-x · Cited by 595
The Protein Kinase C Family for Neuronal Signaling
Tanaka, C., & Nishizuka, Y. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003003 · Cited by 543
Papp, M., Willner, P., & Muscat, R. (1991) · Psychopharmacology · doi:10.1007/bf02244188 · Cited by 542
The role of protein kinase C activation and the vascular complications of diabetes
Daş-Evcimen, N., & KING, G. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.04.016 · Cited by 503
Research works printed but not linked: 3
- Birnbaum, 2004, Science, 306, 882, 10.1126/science.1100021 · DOI · Paper page
- Lenox, 1996, J Clin Psychiatry, 57, 23
- Goldstein, 1986, J Clin Psychiatry, 47, 153
Cited by
Sorted by citations
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
Protein kinase C, an elusive therapeutic target?
Mochly‐Rosen, D., Das, K., & Grimes, K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3871 · Cited by 583
Potential Mechanisms of Action of Lithium in Bipolar Disorder
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 484
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Probing the Biology of Natural Products: Molecular Editing by Diverted Total Synthesis
Szpilman, A. M., & Carreira, E. M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904761 · Cited by 221
Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia
Berridge, M. J. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1806-z · Cited by 181
Predominant recurrence polarity among 928 adult international bipolar I disorder patients
Baldessarini, R. J., Undurraga, J. P., Vázquez, G. H., Tondo, L., Salvatore, P., Ha, K., Khalsa, H. ‐. K., Lepri, B., Ha, T. H., Chang, J. S., et al. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01818.x · Cited by 164
A model of the mitochondrial basis of bipolar disorder
Morris, G., Walder, K., McGee, S. L., Dean, O. M., Tye, S. J., Maes, M., & Berk, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.014 · Cited by 162
Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
Li, X., Frye, M. A., & Shelton, R. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.198 · Cited by 131
Effects of lithium therapy on Na+–K+-ATPase activity and lipid peroxidation in bipolar disorder
Banerjee, U., Dasgupta, A., Rout, J. K., & Singh, O. P. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.006 · Cited by 128
Protein kinase C and cardiac dysfunction: a review
Singh, R. M., Cummings, E., Pantos, C. I., & Singh, J. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9634-3 · Cited by 117
Singh, N., Sharpley, A. L., Emir, U. E., Masaki, C., Herzallah, M. M., Gluck, M. A., Sharp, T., Harmer, C. J., Vasudevan, S. R., Cowen, P. J., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.343 · Cited by 107
Towards a multifactorial approach for prediction of bipolar disorder in at risk populations
Brietzke, E. M., Mansur, R. B., Soczynska, J. K., Kapczinski, F. P., Bressan, R. A., & McIntyre, R. S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.016 · Cited by 103
Sun, M., & Alkon, D. L. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-420170-5.00002-7 · Cited by 94
Amrollahi, Z., Rezaei, F., Salehi, B., Modabbernia, A., Maroufi, A., Esfandiari, G.-R., Naderi, M., Ghebleh, F., Abhari, S. A. A., Sadeghi, M., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.015 · Cited by 92
Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature
Saxena, A., Scaini, G., Bavaresco, D. V., Leite, C., Valvassoria, S. S., Carvalho, A. F., & Quevedo, J. (2017) · Complex Psychiatry · doi:10.1159/000480349 · Cited by 85
Protein kinase C (PKC) isozyme-specific substrates and their design
Kang, J., Toita, R., Kim, C. W., & Katayama, Y. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.07.004 · Cited by 84
Protein Kinase C (PKC) Isozymes and Cancer
Kang, J. (2014) · New Journal of Science · doi:10.1155/2014/231418 · Cited by 83
Wong, E. H. F., Tarazi, F. I., & Shahid, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.001 · Cited by 78
Machado‐Vieira, R., Soeiro‐de‐Souza, M. G., Richards, E. M., Teixeira, A. L., & Zarate, C. A. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.830775 · Cited by 71
Self-citationTargeting telomerase for its advent in cancer therapeutics
Bajaj, S., Kumar, M. S., Peters, G. J., & Mayur, Y. (2020) · Medicinal Research Reviews · doi:10.1002/med.21674 · Cited by 72
Szpilman, A. M., & Carreira, E. M. (2010) · Angewandte Chemie · doi:10.1002/ange.200904761 · Cited by 63
Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview
Ochoa, E. L. M. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01129-9 · Cited by 68
Lazarevic, V., Yang, Y., Ivanova, D., Fejtová, A., & Svenningsson, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.021 · Cited by 61
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Bortolozzi, A. A., Fico, G., Berk, M., Solmi, M., Fornaro, M., Quevedo, J., Zarate, C. A., Kessing, L. V., Vieta, E., & Carvalho, A. F. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000007 · Cited by 68
Self-citationNeuropsychiatric effects of tamoxifen: Challenges and opportunities
Novick, A. M., Scott, A. T., Epperson, C. N., & Schneck, C. D. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100869 · Cited by 61
Nutrient-Based Therapies for Bipolar Disorder: A Systematic Review
Sylvia, L. G., Peters, A. T., Deckersbach, T., & Nierenberg, A. A. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000341309 · Cited by 55
Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats
Abrial, E., Etiévant, A., Betry, C., Scarna, H., Lucas, G., Haddjeri, N., & Lambás‐Señas, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.015 · Cited by 53
Tamoxifen for bipolar disorder: Systematic review and meta-analysis
Palacios, J. E., Yıldız, A., Young, A. H., & Taylor, M. J. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118822167 · Cited by 50
Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression
Mayati, A., Moreau, A., Vée, M. L., Stieger, B., Denizot, C., Parmentier, Y., & Fardel, O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040764 · Cited by 47
Valvassori, S. S., Arent, C. O., Steckert, A. V., Varela, R. B., Jornada, L. K., Tonin, P. T., Budni, J., Mariot, E., Kapczinski, F. P., & Quevedo, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8873-8 · Cited by 44
Ahmad, A., Sheikh, S., Khan, M. A., Chaturvedi, A., Patel, P. M., Patel, R. B., Buch, B. C., Anand, R. S., Shah, T. C., Vora, V. N., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.13041 · Cited by 44
Bipolar disorder: candidate drug targets
Zarate, C. A., & Manji, H. K. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20042 · Cited by 42
Self-citationSilnitsky, S., Rubin, S. J. S., Zerihun, M., & Qvit, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417600 · Cited by 45
Molecular Mechanisms of Amphetamines
Reith, M. E. A., & Gnegy, M. E. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_251 · Cited by 45
Wöhr, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15487 · Cited by 41
Bao, H., Thai, T. L., Yue, Q., Ma, H., Eaton, A. F., Cai, H., Klein, J. D., Sands, J. M., & Eaton, D. C. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00519.2013 · Cited by 42
Talaeı, A., Pourgholami, M., Khatibi-Moghadam, H., Farıdhosseını, F., Farhoudi, F., Askari-Noghani, A., & Sadeghi, R. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000492 · Cited by 38
Protein phosphorylation detection using dual-mode field-effect devices and nanoplasmonic sensors
Bhalla, N., Lorenzo, M. D., Pula, G., & Estrela, P. (2015) · Scientific Reports · doi:10.1038/srep08687 · Cited by 37
Castaldo, M., Zollo, C., Esposito, G., Ammendola, R., & Cattaneo, F. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2051235 · Cited by 36
Li, J., Ziemba, B. P., Falke, J. J., & Voth, G. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505369r · Cited by 33
Tamoxifen use for the management of mania: a review of current preclinical evidence
Armani, F., Andersen, M. L., & Galduróz, J. C. F. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3397-x · Cited by 29
Barbosa, F. J. L., Hesse, B., de Almeida, R. B., Baretta, I. P., Boerngen-Lacerda, R., & Andreatini, R. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70399-1 · Cited by 29
Kinase Targets in Cns Drug Discovery
Gunosewoyo, H., Yu, L.-F., Munoz, L., & Kassiou, M. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0214 · Cited by 27
Martín‐Sánchez, F., Mora, L., Laorden, M. L., & Milanés, M. V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01287.x · Cited by 27
Carpenter, C., Zestos, A. G., Altshuler, R. D., Sorenson, R. J., Guptaroy, B., Showalter, H. D., Kennedy, R. T., Jutkiewicz, E. M., & Gnegy, M. E. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.95 · Cited by 27
Valvassori, S. S., Dal-Pont, G. C., Resende, W. R., Varela, R. B., Peterle, B. R., Gava, F. F., Mina, F., Cararo, J. H., Carvalho, A. F., & Quevedo, J. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx049 · Cited by 25
Statin-specific inhibition of Rab-GTPase regulates cPKC-mediated IKs internalization
Ronzier, E., Parks, X. X., Qudsi, H., & Lopes, C. M. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-53700-6 · Cited by 25
Bray, J. G., & Mynlieff, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.054 · Cited by 24
Garzón-Niño, J., Rodríguez-Muñoz, M., Cortés‐Montero, E., & Sánchez‐Blázquez, P. (2017) · Scientific Reports · doi:10.1038/srep43468 · Cited by 24
Antipsychotics in the Treatment of Bipolar Disorder
Singh, J. B., Chen, G., & Canuso, C. M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_8 · Cited by 25
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
Machado‐Vieira, R., Courtes, A. C., Zarate, C. A., Henter, I. D., & Manji, H. K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1228455 · Cited by 25
Self-citationKoenigsberg, H. W., Yuan, P., Diaz, G. A., Guerreri, S., Dorantes, C., Mayson, S. J., Zamfirescu, C.-B., New, A. S., Goodman, M. S., Manji, H. K., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.04.026 · Cited by 23
Self-citationKaranges, E. A., Kashem, M., Sarker, R., Ahmed, E. U., Ahmed, S., van Nieuwenhuijzen, P. V., Kemp, A., & McGregor, I. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00086 · Cited by 24
Behavioral Neurobiology of Bipolar Disorder and its Treatment
Manji, H. K., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-15757-8 · Cited by 20
Self-citationTamoxifen and amphetamine abuse: Are there therapeutic possibilities?
Mikelman, S. R., Mardirossian, N., & Gnegy, M. E. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.08.004 · Cited by 20
Prescribing Tamoxifen in Patients With Mood Disorders
Carmassi, C., Cordone, A., Dell’Oste, V., Pedrinelli, V., Pardini, F., Simoncini, M., & Dell’Osso, L. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001412 · Cited by 19
da Silva, T. R., Sohn, J. M. B., Andreatini, R., & Stern, C. A. J. (2020) · Learning & Memory · doi:10.1101/lm.051615.120 · Cited by 19
Intracellular Signaling Cascades in Bipolar Disorder
Jones, G. H., Rong, C., Shariq, A. S., Mishra, A. P., & Machado‐Vieira, R. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_157 · Cited by 18
Li, D., Tsai, S., Bai, Y., Su, T., Chen, T., Liang, C., & Chen, M. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103355 · Cited by 16
Lithium affects the circadian clock in the choroid plexus – A new role for an old mechanism
Liška, K., Dočkal, T., Houdek, P., Sládek, M., Lužná, V., Semenovykh, K., Drapšin, M., & Sumová, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114292 · Cited by 18
Lithium in Medicine: Mechanisms of Action
de Freitas, D. M., Leverson, B. D., & Goossens, J. L. (2016) · Metal ions in life sciences · doi:10.1007/978-3-319-21756-7_15 · Cited by 18
DGKH genetic risk variant influences gene expression in bipolar affective disorder
Kittel‐Schneider, S., Lorenz, C., Auer, J., Weißflog, L., & Reif, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.041 · Cited by 17
Oestradiol and Psychosis: Clinical Findings and Biological Mechanisms
Wieck, A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_127 · Cited by 15
Valvassori, S. S., Borges, C. P., Varela, R. B., Bavaresco, D. V., Bianchini, G., Mariot, E., Arent, C. O., Resende, W. R., Budni, J., & Quevedo, J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.08.006 · Cited by 15
Parks, X. X., Ronzier, E., O‐Uchi, J., & Lopes, C. M. B. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.03.016 · Cited by 15
Current and Emerging Therapies for the Management of Bipolar Disorders
El‐Mallakh, R. S., Elmaadawi, A. Z., Gao, Y., Lohano, K., & Roberts, R. J. (2011) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s4441 · Cited by 15
A critical evaluation of dynamical systems models of bipolar disorder
Nunes, A., Singh, S., Allman, J., Becker, S., Ortiz, A., Trappenberg, T. P., & Alda, M. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02194-4 · Cited by 14
Dal-Pont, G. C., Resende, W. R., Bianchini, G., Gava, F. F., Peterle, B. R., Trajano, K. S., Varela, R. B., Quevedo, J., & Valvassori, S. S. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.020 · Cited by 14
Einat, H. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.03.013 · Cited by 13
Yıldız, A., Aydın, B., Gökmen, N., Yurt, A., Cohen, B. M., Keskinoğlu, P., Öngür, D., & Renshaw, P. F. (2015) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.12.002 · Cited by 13
Valvassori, S., Cararo, J. H., Peper-Nascimento, J., Ferreira, C., Gava, F. F., Dal-Pont, G. C., Andersen, M., & Quevedo, J. (2020) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109940 · Cited by 11
Kim, S. H., Kim, M. K., Yu, H. S., Kim, H., Park, I. S., Park, H. G., Kang, U. G., & Kim, Y. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.10.009 · Cited by 12
Calcium in Signaling: Its Specificity and Vulnerabilities toward Biogenic and Abiogenic Metal Ions
Dudev, T., Grauffel, C., & Lim, C. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c05154 · Cited by 11
Chen, G., Henter, I. D., & Manji, H. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909771106 · Cited by 10
Self-citationPhylogeny and distribution of protein kinase C variants in the zebrafish
Haug, M. F., Gesemann, M., Berger, M., & Neuhauss, S. C. F. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24395 · Cited by 9
Proteomic Analysis of Rat Prefrontal Cortex after Chronic Lithium Treatment
Lakshmanan, J., & Seelan, R. S. (2012) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000226 · Cited by 9
Amiri, S., Azadmanesh, K., Shasaltaneh, M. D., Mayahi, V., & Naghdi, N. (2019) · Iranian Biomedical Journal · doi:10.29252/ibj.24.2.64 · Cited by 8
Clinical insights by the presence of bipolar disorder in pseudohypoparathyroidism type 1A
Kadilli, I., Colicchio, S., Guglielmo, R., Vollono, C., Marca, G. D., & Janiri, L. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.06.008 · Cited by 7
Sigma 1 Receptor Antagonists Inhibit Manic-Like Behaviors in Two Congenital Strains of Mice
Sánchez‐Blázquez, P., Cortés‐Montero, E., Rodríguez-Muñoz, M., & Garzón, J. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy049 · Cited by 7
The Use of Tamoxifen as a Potential Treatment for Bipolar Disorder
Bagdadi, N., Azab, A. N., & Shvartsur, R. (2021) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2021.21817 · Cited by 7
Trinuclear Calcium Site in the C2 Domain of PKCα/γ Is Prone to Lithium Attack
Grauffel, C., Weng, W.-H., Dudev, T., & Lim, C. (2021) · ACS Omega · doi:10.1021/acsomega.1c02882 · Cited by 7
Ahmadi, S., Faridi, S., & Tahmasebi, S. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112009 · Cited by 6
Real-World Long-Term Experience on Endoxifen in Bipolar Disorder with Psychotic Symptoms
Thanvi, V. (2022) · Case Reports in Psychiatry · doi:10.1155/2022/3684181 · Cited by 6
Hallen, A., & Cooper, A. J. L. (2020) · Genes · doi:10.3390/genes11040446 · Cited by 7
Meyer, H., Reilly, D. E., Martin, S. E., & Wong, A. W. (2017) · Biotechnology Progress · doi:10.1002/btpr.2488 · Cited by 6
Proteomic analysis of rat prefrontal cortex after chronic valproate treatment
Thangavel, M., Seelan, R. S., Lakshmanan, J., Vadnal, R. E., Stagner, J. I., Parthasarathy, L. K., Casanova, M. F., El-Mallakh, R. S., & Parthasarathy, R. N. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23373 · Cited by 5
Effects of Synthetic Peptides on the Inflammatory Response and their Therapeutic Potential
Selvatici, R., Siniscalchi, A., & Spisani, S. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557511313040008 · Cited by 5
Lithium Response Variability: New Avenues and Hypotheses
Bellivier, F., & Cynthia Marie-claire, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-45923-3_9 · Cited by 5
Starosyla, S. A., Volynets, G. P., Protopopov, M., Bdzhola, V. G., Pashevin, D. O., Polishchuk, V. O., Kozak, T. O., Stroi, D. O., Dosenko, V., & Yarmoluk, S. M. (2022) · Structural Chemistry · doi:10.1007/s11224-022-02075-y · Cited by 5
Potential Novel Therapeutics for Bipolar Disorders
Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_51 · Cited by 6
Self-citationBaldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_3 · Cited by 5
Metal Ion Imbalance in the Body
Dabrowiak, J. C. (2017) · Wiley eBooks · doi:10.1002/9781119191377.ch8 · Cited by 5
Filev, A. D., Ershova, E. S., Savinova, E. A., Кalakov, A. M., Вейко, Н. Н., Umriukhin, P. E., & Kostyuk, S. V. (2021) · International Journal of Biology and Biomedical Engineering · doi:10.46300/91011.2021.15.45 · Cited by 4
Sasa Quelpaertensis Nakai Induced Antidepressant-Like Effect in Ovariectomized Rats
Shaif, N. A. S., Cho, D., Jang, D., Kim, H. M., Chung, J., Kim, S., Seo, D. B., Kim, K.-R., Shin, J., & Shim, I. (2019) · BioMed Research International · doi:10.1155/2019/5815604 · Cited by 6
PKC in rat dorsal raphe nucleus plays a key role in sleep–wake regulation
Li, S., Cui, S., Zhang, X., Yu, B., Sheng, Z., Huang, Y., Cao, Q., Xu, Y.-P., Lin, Z.-X., Yang, G., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.005 · Cited by 4
Moreira, J., Noé, G., Rangarajan, S., Courtin, C., Étain, B., Geoffroy, P. A., Laplanche, J., Vidal, M., Bellivier, F., & Cynthia Marie-claire, A. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1487078 · Cited by 4
Increased Seizure Threshold Related to Tamoxifen
Stewart, J. T., & Kahn, D. A. (2014) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000456597.51116.85 · Cited by 4
Toward Early, Personalized, Rational Polypharmacy In Psychiatry
Niculescu, A. B., & Hulvershorn, L. A. (2010) · Psychopharm Review · doi:10.1097/01.idt.0000366925.86837.fe · Cited by 4
Pharmacotherapy of bipolar disorder: current status and emerging options
Sandlin, E. K., Gao, Y., & El‐Mallakh, R. S. (2013) · Clinical Practice · doi:10.2217/cpr.13.85 · Cited by 2
Metadata
- Authors
- Zarate, C. A., & Manji, H. K.
- Affiliations
- National Institutes of Health (US)
- National Institute of Mental Health (US)
- Corresponding author
- Zarate, Carlos A.
- Venue
- CNS Drugs
- Published
- 2009-07
- Volume
- 23
- Issue
- 7
- Pages
- 569-582
- ISSN
- 1172-7047 (ISSN-L)
- PMC
- PMC2802274
- OpenAlex
- W2139699538
- Cited by
- 122
- References
- 80
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 10 · 2018: 5 · 2017: 13 · 2016: 6 · 2015: 6 · 2014: 10 · 2013: 7 · 2012: 12
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (Z01MH002830)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- protein kinase C, PKC inhibitors, bipolar disorder, mania, lithium, valproic acid, tamoxifen, targeted therapy, genome-wide association study
- MeSH terms
- Animals, Bipolar Disorder, Clinical Trials as Topic, Humans, Models, Biological, Protein Kinase C, Antimanic Agents, Protein Kinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review